What it is
GLP-1 receptor agonists are a class of prescription medications that mimic a gut hormone involved in appetite and blood-sugar regulation. Several branded products in this class are FDA-approved for diabetes and weight management. They are the most significant metabolic drugs of the past decade.
What is currently understood
Large, well-run human trials support their effects on blood sugar and body weight in the populations studied, under medical supervision. This is the strongest evidence base of anything in this library.
What is not established
Long-term outcomes in healthy, non-diabetic users are still being studied. Questions around lean-mass preservation, discontinuation and weight regain are active research areas, and the quality of compounded versions is a documented concern.
Regulatory status
Several are FDA-approved as branded prescription products. Compounded versions became widely available during the 2023 to 2025 shortage period; following resolution of those shortages the legal basis for compounding them is restricted and contested, and is an active enforcement area.
How it comes up in coaching
It comes up in almost every metabolic conversation. Coaching covers the training, protein and lifestyle context that determines whether any metabolic intervention holds, and every prescribing decision belongs to a licensed provider. Nothing here is a recommendation.
This page is educational. It is not medical advice, not a recommendation, and not an offer to supply anything. Whether any intervention is appropriate for you is a decision for a licensed provider.